Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Page 1
HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR).
Pogozhykh D, Yilmaz Karapinar D, Klimiankou M, Gerschmann N, Ebetsberger-Dachs G, Palmblad J, Carlsson G, Masmas T, Kinsey S, Bartels M, Mellor-Heineke S, Welte K, Skokowa J, Zeidler C. Pogozhykh D, et al. Among authors: palmblad j. Br J Haematol. 2023 Jul;202(2):393-411. doi: 10.1111/bjh.18840. Epub 2023 May 16. Br J Haematol. 2023. PMID: 37193639
HAX1-CN patients suffer from bone marrow failure as assessed by a maturation arrest of the myelopoiesis revealing persistent severe neutropenia from birth. The disorder is strongly associated with severe bacterial infections and a high risk of developing myelodysplastic sy …
HAX1-CN patients suffer from bone marrow failure as assessed by a maturation arrest of the myelopoiesis revealing persistent severe neutrope …
DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study.
Karimi M, Vedin I, Freund Levi Y, Basun H, Faxén Irving G, Eriksdotter M, Wahlund LO, Schultzberg M, Hjorth E, Cederholm T, Palmblad J. Karimi M, et al. Among authors: palmblad j. Am J Clin Nutr. 2017 Oct;106(4):1157-1165. doi: 10.3945/ajcn.117.155648. Epub 2017 Aug 30. Am J Clin Nutr. 2017. PMID: 28855224 Free article. Clinical Trial.
., docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3)], modulate inflammatory reactions through various mechanisms, including gene expression, which is measured as messenger RNA concentration. However, the effects of long-term treatment of humans …
., docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3)], modulate inflammatory reactions through various mechanisms …
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-up.
Ejerblad E, Kvasnicka HM, Thiele J, Andreasson B, Björkholm M, Löfvenberg E, Markevärn B, Merup M, Nilssson L, Palmblad J, Samuelsson J, Birgegård G. Ejerblad E, et al. Among authors: palmblad j. Hematology. 2013 Jan;18(1):8-13. doi: 10.1179/1607845412Y.0000000023. Epub 2012 Sep 14. Hematology. 2013. PMID: 22990042 Clinical Trial.
OBJECTIVES: During long term follow-up of a cohort of patients with essential thrombocythemia (ET) and polycythemia vera (PV) a higher than expected incidence of myelofibrosis (MF) was noted. ...METHODS: This prospective study of 60 patients with ET and PV was set up in 19 …
OBJECTIVES: During long term follow-up of a cohort of patients with essential thrombocythemia (ET) and polycythemia vera (PV) a highe …
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study.
Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, Eriksdotter-Jönhagen M, Wahlund LO, Dahlman I, Palmblad J. Vedin I, et al. Among authors: palmblad j. PLoS One. 2012;7(4):e35425. doi: 10.1371/journal.pone.0035425. Epub 2012 Apr 24. PLoS One. 2012. PMID: 22545106 Free PMC article. Clinical Trial.
BACKGROUND: Dietary fish oil, rich in n-3 fatty acids (n-3 FAs), e.g. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), regulate inflammatory reactions by various mechanisms, e.g. gene activation. However, the effects of long-term treatment with DHA and EPA in hu …
BACKGROUND: Dietary fish oil, rich in n-3 fatty acids (n-3 FAs), e.g. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), regulate i …
Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.
Berntorp E, Astermark J, Baghaei F, Bergqvist D, Holmström M, Ljungberg B, Norlund A, Palmblad J, Petrini P, Stigendal L, Säwe J. Berntorp E, et al. Among authors: palmblad j. Haemophilia. 2012 Mar;18(2):158-65. doi: 10.1111/j.1365-2516.2011.02723.x. Epub 2011 Dec 12. Haemophilia. 2012. PMID: 22151198 Review.
In an ongoing health-technology assessment of haemophilia treatment in Sweden, performed by the governmental agency Dental and Pharmaceutical Benefits Agency (TLV; tandvards-och lakemedelsformansverket), the Swedish Council on Health Technology Assessment (SBU; statens beredning …
In an ongoing health-technology assessment of haemophilia treatment in Sweden, performed by the governmental agency Dental and Pharmaceutica …
Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
Cederholm T, Palmblad J. Cederholm T, et al. Among authors: palmblad j. Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):150-5. doi: 10.1097/MCO.0b013e328335c40b. Curr Opin Clin Nutr Metab Care. 2010. PMID: 20019606 Review.
It is unlikely that n-3 FA will emerge as a treatment option in general for improving cognitive function in patients with Alzheimer's disease. n-3 FA, especially DHA, may turn out as an adjuvant therapy in selected cases. Further long-term intervention studies on individua …
It is unlikely that n-3 FA will emerge as a treatment option in general for improving cognitive function in patients with Alzheimer's diseas …
Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia.
Carlsson G, Melin M, Dahl N, Ramme KG, Nordenskjöld M, Palmblad J, Henter JI, Fadeel B. Carlsson G, et al. Among authors: palmblad j. Acta Paediatr. 2007 Jun;96(6):813-9. doi: 10.1111/j.1651-2227.2007.00274.x. Acta Paediatr. 2007. PMID: 17537008 Review.
Congenital neutropenia in man was first reported 50 years ago by the Swedish paediatrician Rolf Kostmann. He coined the term 'infantile genetic agranulocytosis' for this condition, which is now known as Kostmann syndrome. ...
Congenital neutropenia in man was first reported 50 years ago by the Swedish paediatrician Rolf Kostmann. He coined the term 'infanti …
Kostmann syndrome or infantile genetic agranulocytosis, part one: celebrating 50 years of clinical and basic research on severe congenital neutropenia.
Carlsson G, Andersson M, Pütsep K, Garwicz D, Nordenskjöld M, Henter JI, Palmblad J, Fadeel B. Carlsson G, et al. Among authors: palmblad j. Acta Paediatr. 2006 Dec;95(12):1526-32. doi: 10.1080/08035250601087607. Acta Paediatr. 2006. PMID: 17129957
Congenital neutropenia in man was first reported 50 years ago by the Swedish paediatrician Rolf Kostmann. He coined the term "infantile genetic agranulocytosis" for this condition, which is now known as Kostmann syndrome. ...
Congenital neutropenia in man was first reported 50 years ago by the Swedish paediatrician Rolf Kostmann. He coined the term "infanti …
13 results